← FDA Drug Approvals (Drugs@FDA)

YARTEMLEA

BLA · Biologics License Application · Sponsor: OMEROS CORP · Approved 2025-12-23

Drug application

FDA Application #

BLA761152

Application type

Biologics License Application

Brand name

YARTEMLEA

Generic name

NARSOPLIMAB

Active ingredients

NARSOPLIMAB-WUUG

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

OMEROS CORP

Manufacturer

Omeros Corporation

First approval

2025-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown